Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05371756 · ClinicalTrials.gov registry record
The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.
A clinical trial of Cancer, sponsored by Baylor Research Institute.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 8
- Study locations
NCT05371756: Recruiting study of Cancer, sponsored by Baylor Research Institute.
NCT05371756 is a study of Cancer that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 10,000 participants, above the 3,475-participant average among 615 other Cancer trials with a reported enrollment target (188% higher). The trial reports 8 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05371756, a study of Cancer, is actively recruiting participants, sponsored by Baylor Research Institute.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of the Texas Immuno-Oncology Biorepository (TIOB) is to collect and store well-defined and well-annotated serial biospecimens of tissue, blood, urine and stool in a longitudinal manner from cancer patients who are receiving either standard of care surgical interventions and or FDA approved immunotherapeutics across the largest not-for-profit health system in Texas. Comprehensive clinical and radiological data from a diverse population of patients with different racial, social and ethnic backgrounds matched with serial biospecimens over a patients journey with cancer marks the TIOB as a unique research facility.
Primary Outcome
Develop a biorepository that ensures molecular integrity and clinical relevance of quality human biospecimens and associated patho-clinical data for development of new diagnostic and therapeutic technology.
Conditions Studied
Study Locations (8)
Texas
- Baylor Scott & White Medical Center - College Station - College Station
- Baylor University Medical Center - Dallas - Dallas
- Baylor Scott & White All Saints Medical Center - Fort Worth - Fort Worth
- Baylor Scott & White Medical Center - Plano - Plano
- Baylor Scott & White Medical Center - Round Rock - Round Rock
- Baylor Scott & White Medical Center - Temple - Temple
- Baylor Scott & White Medical Center - Hillcrest - Waco
- Baylor Scott & White Medical Center - Waxahachie - Waxahachie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2020-09-11 |
| Est. Completion | 2050-09-11 |
What NCT05371756 shows while recruiting
NCT05371756 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 3,475-participant average among 615 other Cancer trials with a reported enrollment target (188% higher).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT05371756 lists 8 locations in 1 state (Texas).
Frequently Asked Questions
What is clinical trial NCT05371756 about?
NCT05371756 is a clinical study titled "The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.". The purpose of the Texas Immuno-Oncology Biorepository (TIOB) is to collect and store well-defined and well-annotated serial biospecimens of tissue, blood, urine and stool in a longitudinal manner from cancer patients who are receiving either standard of care surgical interventions and or FDA approv...
What is the current status of trial NCT05371756?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2020-09-11. Estimated completion is 2050-09-11.
What conditions does trial NCT05371756 study?
This clinical trial studies the following conditions: Cancer.
Who is sponsoring clinical trial NCT05371756?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05371756 being conducted?
This trial has 8 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05371756's enrollment target sits among peer trials
10,000 23rd of 615 higher than 584 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
- NCT01000883 · 10,000 participants
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI